403 related articles for article (PubMed ID: 8453211)
1. Progressive systemic sclerosis sine scleroderma in a child presenting as nocturnal seizures and Raynaud's phenomenon.
Navon P; Halevi A; Brand A; Branski D; Rubinow A
Acta Paediatr; 1993 Jan; 82(1):122-3. PubMed ID: 8453211
[TBL] [Abstract][Full Text] [Related]
2. Primary Raynaud's phenomenon, very early and early scleroderma tips for a timely diagnosis.
Sirufo MM; Magnanimi LM; Ginaldi L; De Martinis M
Eur J Intern Med; 2022 Apr; 98():111-112. PubMed ID: 35120748
[No Abstract] [Full Text] [Related]
3. Raynaud's features in childhood. Clinical, immunological and capillaroscopic study.
Navon P; Yarom A; Davis E
J Mal Vasc; 1992; 17(4):273-6. PubMed ID: 1494054
[TBL] [Abstract][Full Text] [Related]
4. Nailfold capillaroscopy for the early diagnosis of the scleroderma spectrum of diseases in patients without Raynaud's phenomenon.
Hong C; Xiang L; Saffari SE; Low AH
J Scleroderma Relat Disord; 2022 Jun; 7(2):144-150. PubMed ID: 35585956
[TBL] [Abstract][Full Text] [Related]
5. [A case of amyopathic dermatomyositis with systemic sclerosis sine scleroderma presenting abnormal vermiculation].
Kubo N; Sawayama Y; Okada K; Nakagawa Y; Asou Y; Nabeshima S; Otsuka T; Kashiwagi S; Hayashi J
Ryumachi; 2002 Aug; 42(4):676-81. PubMed ID: 12355862
[TBL] [Abstract][Full Text] [Related]
6. Chronic dyspnea with Raynaud's phenomenon and elevated ANA: A diagnosis of systemic sclerosis sine scleroderma.
Chong WH; Saha BK; Beegle S
Am J Med Sci; 2023 Feb; 365(2):198-204. PubMed ID: 35276077
[TBL] [Abstract][Full Text] [Related]
7. [Raynaud's phenomena: diagnostic and treatment study].
Priollet P
Rev Prat; 1998 Oct; 48(15):1659-64. PubMed ID: 9814067
[TBL] [Abstract][Full Text] [Related]
8. [Systemic sclerosis with renal involvement in a 15-year old girl diagnosed with lichen sclerosus].
Kniazewska M; Zmudzińska-Kitczak J; Urban K; Obuchowicz A; Wilk M; Rudka R
Pol Merkur Lekarski; 2001 Apr; 10(58):296-7. PubMed ID: 11434184
[TBL] [Abstract][Full Text] [Related]
9. Validation of the 2013 American College of Rheumatology/European League Against Rheumatism classification criteria for systemic sclerosis in patients from a capillaroscopy clinic.
Melchor S; Joven BE; Andreu JL; Loza E; Garcia de Yebenes MJ; Carmona L; Carreira PE
Semin Arthritis Rheum; 2016 Dec; 46(3):350-355. PubMed ID: 27373498
[TBL] [Abstract][Full Text] [Related]
10. Late onset Raynaud's phenomenon, hypertension, deteriorating renal function, and a fit in a middle aged woman.
Hutchinson D; Moots RJ
Postgrad Med J; 2001 Dec; 77(914):E10. PubMed ID: 11723338
[No Abstract] [Full Text] [Related]
11. [Esophageal motility in Raynaud's disease, systemic scleroderma and presclerodermal Raynaud's syndrome].
Hostein J; Bost R; Carpentier P; Franco A; Fournet J
Gastroenterol Clin Biol; 1985 Feb; 9(2):130-5. PubMed ID: 3979734
[TBL] [Abstract][Full Text] [Related]
12. Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.
Lukác J; Rovenský J; Tauchmannová H; Zitnan D
Drugs Exp Clin Res; 1985; 11(9):659-63. PubMed ID: 3916837
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of Systemic Sclerosis Based on Raynaud's Phenomenon, Capillaroscopy Findings, and Autoantibodies in the Absence of Sclerodactyly.
Druyan A; Lidar M
Isr Med Assoc J; 2018 Oct; 20(10):658. PubMed ID: 30324790
[No Abstract] [Full Text] [Related]
14. Reproducibility of the scleroderma pattern assessed by wide-field capillaroscopy in subjects suffering from Raynaud's phenomenon.
Boulon C; Blaise S; Lazareth I; Le Hello C; Pistorius MA; Imbert B; Mangin M; Sintes P; Senet P; Decamps-Le Chevoir J; Tribout L; Carpentier P; Constans J
Rheumatology (Oxford); 2017 Oct; 56(10):1780-1783. PubMed ID: 28957564
[TBL] [Abstract][Full Text] [Related]
15. Raynaud's phenomenon.
Devgire V; Hughes M
Br J Hosp Med (Lond); 2019 Nov; 80(11):658-664. PubMed ID: 31707892
[TBL] [Abstract][Full Text] [Related]
16. The concept of early systemic sclerosis following 2013 ACR\EULAR criteria for the classification of systemic sclerosis.
Valentini G; Marcoccia A; Cuomo G; Iudici M; Vettori S
Curr Rheumatol Rev; 2014; 10(1):38-44. PubMed ID: 24720644
[TBL] [Abstract][Full Text] [Related]
17. [Cardiac tamponade preceding skin involvement in progressive systemic sclerosis].
Peronato G; De Sandre P; Podswiadek M; Arfiero S; Bozzola L
Reumatismo; 2002; 54(3):257-60. PubMed ID: 12404035
[TBL] [Abstract][Full Text] [Related]
18. Progressive systemic sclerosis sine scleroderma presenting as pulmonary interstitial fibrosis.
Lomeo RM; Cornella RJ; Schabel SI; Silver RM
Am J Med; 1989 Nov; 87(5):525-7. PubMed ID: 2683765
[TBL] [Abstract][Full Text] [Related]
19. [Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis].
Serri J; Legré R; Veit V; Guardia C; Gay AM
Ann Chir Plast Esthet; 2013 Dec; 58(6):658-62. PubMed ID: 22204894
[TBL] [Abstract][Full Text] [Related]
20. Prazosin for Raynaud's phenomenon in progressive systemic sclerosis.
Pope J; Fenlon D; Thompson A; Shea B; Furst D; Wells G; Silman A
Cochrane Database Syst Rev; 2000; 1998(2):CD000956. PubMed ID: 10796398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
